A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Clinical trial NCT07745504 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07745504
- Sponsor
- Novo Nordisk A/S
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2027-05-18
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.